Literature DB >> 23177739

A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors.

Jose P Vaqué1, Robert T Dorsam, Xiaodong Feng, Ramiro Iglesias-Bartolome, David J Forsthoefel, Qianming Chen, Anne Debant, Mark A Seeger, Bruce R Ksander, Hidemi Teramoto, J Silvio Gutkind.   

Abstract

Activating mutations in GNAQ and GNA11, encoding members of the Gα(q) family of G protein α subunits, are the driver oncogenes in uveal melanoma, and mutations in Gq-linked G protein-coupled receptors have been identified recently in numerous human malignancies. How Gα(q) and its coupled receptors transduce mitogenic signals is still unclear because of the complexity of signaling events perturbed upon Gq activation. Using a synthetic-biology approach and a genome-wide RNAi screen, we found that a highly conserved guanine nucleotide exchange factor, Trio, is essential for activating Rho- and Rac-regulated signaling pathways acting on JNK and p38, and thereby transducing proliferative signals from Gα(q) to the nucleus independently of phospholipase C-β. Indeed, whereas many biological responses elicited by Gq depend on the transient activation of second-messenger systems, Gq utilizes a hard-wired protein-protein-interaction-based signaling circuitry to achieve the sustained stimulation of proliferative pathways, thereby controlling normal and aberrant cell growth.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177739      PMCID: PMC3545055          DOI: 10.1016/j.molcel.2012.10.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  47 in total

Review 1.  The role of Rho in G protein-coupled receptor signal transduction.

Authors:  V P Sah; T M Seasholtz; S A Sagi; J H Brown
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 2.  Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking.

Authors:  W E Miller; R J Lefkowitz
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

Review 3.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

4.  Potent activation of RhoA by Galpha q and Gq-coupled receptors.

Authors:  Hiroki Chikumi; José Vázquez-Prado; Joan-Marc Servitja; Hiroshi Miyazaki; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2002-05-16       Impact factor: 5.157

5.  Physical and functional interactions of Galphaq with Rho and its exchange factors.

Authors:  S A Sagi; T M Seasholtz; M Kobiashvili; B A Wilson; D Toksoz; J H Brown
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

Review 6.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

7.  Galpha(q) and phospholipase C-beta: turn on, turn off, and do it fast.

Authors:  Elliott M Ross
Journal:  Sci Signal       Date:  2011-02-08       Impact factor: 8.192

8.  Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA.

Authors:  Michelle A Booden; David P Siderovski; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere.

Authors:  Michel Souchet; Elodie Portales-Casamar; David Mazurais; Susanne Schmidt; Isabelle Léger; Jean-Luc Javré; Philippe Robert; Isabelle Berrebi-Bertrand; Antoine Bril; Bernard Gout; Anne Debant; Thierry P G Calmels
Journal:  J Cell Sci       Date:  2002-02-01       Impact factor: 5.285

View more
  67 in total

1.  A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior.

Authors:  Eyal Vardy; J Elliott Robinson; Chia Li; Reid H J Olsen; Jeffrey F DiBerto; Patrick M Giguere; Flori M Sassano; Xi-Ping Huang; Hu Zhu; Daniel J Urban; Kate L White; Joseph E Rittiner; Nicole A Crowley; Kristen E Pleil; Christopher M Mazzone; Philip D Mosier; Juan Song; Thomas L Kash; C J Malanga; Michael J Krashes; Bryan L Roth
Journal:  Neuron       Date:  2015-04-30       Impact factor: 17.173

2.  Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells.

Authors:  Laurence Booth; Jane L Roberts; Cindy Sander; Alshad S Lalani; John M Kirkwood; John F Hancock; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2018-12-20       Impact factor: 4.742

3.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

Review 4.  Uveal melanoma as a target for immune-therapy.

Authors:  Marc Oliva; Antonio J Rullan; Josep M Piulats
Journal:  Ann Transl Med       Date:  2016-05

Review 5.  Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.

Authors:  Victoria Wu; Huwate Yeerna; Nijiro Nohata; Joshua Chiou; Olivier Harismendy; Francesco Raimondi; Asuka Inoue; Robert B Russell; Pablo Tamayo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 6.  G Protein-Coupled Receptor and RhoA-Stimulated Transcriptional Responses: Links to Inflammation, Differentiation, and Cell Proliferation.

Authors:  Olivia M Yu; Joan Heller Brown
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

7.  Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.

Authors:  Tomoyo Okada; Ann Y Lee; Li-Xuan Qin; Narasimhan Agaram; Takahiro Mimae; Yawei Shen; Rachael O'Connor; Miguel A López-Lago; Amanda Craig; Martin L Miller; Phaedra Agius; Evan Molinelli; Nicholas D Socci; Aimee M Crago; Fumi Shima; Chris Sander; Samuel Singer
Journal:  Cancer Discov       Date:  2016-08-30       Impact factor: 39.397

8.  A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation.

Authors:  Amee J George; Brooke W Purdue; Cathryn M Gould; Daniel W Thomas; Yanny Handoko; Hongwei Qian; Gregory A Quaife-Ryan; Kylie A Morgan; Kaylene J Simpson; Walter G Thomas; Ross D Hannan
Journal:  J Cell Sci       Date:  2013-09-17       Impact factor: 5.285

9.  Atypical activation of the G protein Gαq by the oncogenic mutation Q209P.

Authors:  Marcin Maziarz; Anthony Leyme; Arthur Marivin; Alex Luebbers; Prachi P Patel; Zhe Chen; Stephen R Sprang; Mikel Garcia-Marcos
Journal:  J Biol Chem       Date:  2018-10-23       Impact factor: 5.157

10.  GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?

Authors:  Matthew G Field; J William Harbour
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.